We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Miami-based Opko Health, Inc.’s fourth-quarter report highlighted positive activities in the face of a net loss of $213.9 million during the fourth quarter, compared to $147.7 million in the same period the year before.
The pharmaceutical market in Japan is set to rise from around $70 billion in 2016 to $72 billion by 2021, representing a low compound annual growth rate of 0.3%, according to research and consulting firm GlobalData.